Of all the health effects attributed to PFAS, immunotoxicity might be the most consequential for families - and it is arguably the best-documented. The landmark Faroe Islands studies showed that children with higher PFAS blood levels produced fewer antibodies after routine childhood vaccinations. This finding was so robust that the European Food Safety Authority chose immune suppression as the critical endpoint for setting PFAS safety limits for the entire European population.
For parents navigating vaccination schedules and trying to give their children the best immune protection possible, this research deserves a close look.
The Faroe Islands Studies
The research that changed how regulators think about PFAS and the immune system comes primarily from the Faroe Islands - a small Danish archipelago in the North Atlantic where residents have elevated PFAS exposure through their seafood-heavy diet.
Philippe Grandjean and colleagues at Harvard T.H. Chan School of Public Health followed two birth cohorts in the Faroes, measuring PFAS blood levels at ages 5 and 7 and comparing them to antibody concentrations after routine diphtheria and tetanus vaccinations.
The findings, published in JAMA in 2012, were striking:
- Each doubling of serum PFOS concentration at age 5 was associated with a 49% reduction in diphtheria antibody levels
- Each doubling of serum PFOS was associated with a 36% reduction in tetanus antibody levels
- Children in the highest PFOS quartile were significantly more likely to have antibody levels below the clinically protective threshold
This means that some children with high PFAS exposure may not achieve adequate immune protection from vaccines they received on schedule. They got the shots, but their immune systems could not mount a strong enough response.
A follow-up study in 2017 extended these findings to age 13, showing that the immune suppression effect persisted through adolescence. The association was not limited to PFOS - PFOA and other PFAS compounds also showed inverse associations with vaccine antibody response.
Why EFSA Made This the Benchmark
In 2020, the European Food Safety Authority published its updated risk assessment for PFAS and made a decision that surprised many observers: instead of using liver toxicity, cancer, or reproductive effects as the critical health endpoint, EFSA chose vaccine antibody response in children.
The reasoning was sound. Immunotoxicity occurred at lower PFAS exposure levels than other health effects. The Faroe Islands data showed measurable immune suppression at blood PFAS concentrations found in the general European population - not just in heavily contaminated communities. This made it the most sensitive endpoint and therefore the most health-protective basis for setting exposure limits.
EFSA set a tolerable weekly intake (TWI) of 4.4 ng/kg body weight per week for the sum of four PFAS: PFOA, PFOS, PFHxS, and PFNA. This is dramatically lower than previous safety thresholds and reflects how seriously European regulators assessed the immunotoxicity evidence.
For context, a substantial portion of the European population exceeds this TWI based on routine dietary and water exposure. The limit essentially says: the current level of PFAS exposure in ordinary life is already high enough to affect children's immune function.
The NTP Systematic Review
In 2016, the US National Toxicology Program published a systematic review evaluating whether PFOA and PFOS are immune hazards to humans. After assessing all available human and animal evidence, the NTP reached the following conclusions:
- PFOS is "presumed to be an immune hazard to humans" based on a "high" confidence level in the evidence
- PFOA is "presumed to be an immune hazard to humans" based on a "moderate" confidence level
The NTP review considered not just vaccine response but also susceptibility to infectious disease, autoimmune effects, and allergic sensitization. The vaccine antibody data was the strongest line of evidence, but the broader immune suppression picture was consistent across multiple study types.
How PFAS Suppress Immune Function
The mechanisms behind PFAS immunotoxicity involve multiple arms of the immune system.